
Danish pharmaceutical firm Zealand Pharma is not new to developing peptide-based drugs, but is now adding another tool to its toolbox by partnering up with Iktos, a French startup company specialized in artificial intelligence, according to a press release.
With a number of successful peptide projects behind Zealand Pharma, the collaboration with leverage the Danish firm’s expertise and Iktos’s capabilities in machine learning and AI to develop a technology for peptide drug design.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app